Resumen
Este artículo presenta una revisión extensa de los antecedentes, las definiciones, la patología y las manifestacio- nes clínicas del deterioro cognoscitivo y de su posible evolución hacia la demencia. También analiza las pruebas necesarias para el diagnóstico oportuno y preciso del deterioro cognoscitivo y su diferenciación con la demencia.
Para terminar hace un análisis de las intervenciones terapéuticas farmacológicas y no farmacológicas, tanto en las fases iniciales del deterioro cognoscitivo como de la demencia, resaltando siempre su impacto en la calidad del paciente, su familia y su entorno social.
Citas
PETERSEN RC, SMITH GE, WARING SC, ET AL. Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997; 9:65–9.
PORTET F, OUSSET PJ, VISSER PJ, ET AL. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. J Neurol Neurosurg Psychiatry 2006; 77;714-718.
GAUTHIER S, REISBERG B, ZAUDIG M, ET AL. Mild cognitive impairment. Lancet 2006; 367: 1262–70.
PETERSEN RC. Mild cognitive impairment. Con- tinuum Lifelong Learning. Neurol 2007;13:15–38.
VOISIN T, TOUCHON J, VELLAS B. Mild cog- nitive impairment: a nosological entity? Curr Opin Neurol 2003;16: Suppl 2:S43-5.
BENNETT DA. Mild cognitive impairment. Clin Geiatr Med 2004; 20: 15– 25.
MORRIS JC. Mild cognitive impairment is early stage Alzheimer disease: time to revise diagnostic cri- teria. Arch Neurol 2006;63:15-6.
TUOKKO H, ZARIT SH. Mild cognitive impair- ment. Aging Ment Health 2003;7:235-7.
PETERSEN RC, SMITH GE, WARING, SC, ET AL. Mild cognitive impairment: clinical characteriza- tion and outcome. Arch Neurol 1999; 56:303-308.
BISCHKOPF J, BUSSE A, ANGERMEYER, MC. Mild cognitive impairment--a review of preva- lence, incidence and outcome according to current approaches. Acta Psychiatr Scand 2002; 106: 403-414.
VOISIN T, TOUCHON J, VELLAS B. Mild cog- nitive impairment: a nosological entity?. Curr Opin Neurol 2003; 16 Suppl 2:S43-5.
MANLY JJ, BELL-MCGINTY S, TANG MX, SCHUPF N, STERN Y, MAYEUX R. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol 2005; 62:1739-46.
PETERSEN RC, STEVENS JC, GANGULI M, ET AL. Practice parameter: early detection of demen- tia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcom- mittee of the American Academy of Neurology. Neurology 2001; 56:1133-1142.
BURNS A, ZAUDIG M. Mild cognitive impair- ment in older people. Lancet 2002; 360:1963-5.
RITCHIE K, ARTERO, S, TOUCHON, J. Clas- sification criteria for mild cognitive impairment: A population-based validation study. Neurology 2001; 56: 37-42.
FISK JD, MERRY, HR, ROCKWOOD K. Varia- tions in case definition affect prevalence but not out- comes of mild cognitive impairment. Neurology 2003; 61: 1179-84.
WINBLAD, B, PALMER, K, KIPIVELTO M, JELIC V, FRATIGLIONI L, WAHLUND LO, ET AL. Mild cognitive impairment: Beyond controver- sies, towards a consensus-report of the international Working Group on Mild Cognitive Impairment. Jour- nal of Internal Medicine 2004: 256, 240–246.
GANGULI M, DODGE HH, SHEN C, ET AL. Mild cognitive impairment, amnestic type: An epide- miologic study. Neurology 2004; 63:115-121.
MORRIS JC, STORANDT M, MILLER JP, ET AL. Mild cognitive impairment represents early-stage Alzheimer’s disease. Arch Neurol 2001; 58:397-405.
MEYER JS, XU G, THORNBY J, CHOWDHURY MH, QUACH M. Is mild cognitive impairment pro- dromal for vascular dementia like Alzheimer’s dis- ease? Stroke 2002; 33:1981-5.
ROMAN GC, SACHDEV P, ROYALL DR, ET AL. Vascular cognitive disorder: a new diagnostic cat- egory updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004;226:81-7.
BOYLE PA, WILSON RS, AGGARWAL NT, ET AL. Parkinsonian signs in subjects with mild cognitive impairment. Neurology 2005; 65:1901-6.
LOUIS ED, SCHUPF N, MANLY J, MARDER K, TANG MX, MAYEUX R. Association between mild parkinsonian signs and mild cognitive impairment in a community.Neurology 2005; 12; 64:1157-61.
BOZOKI A, GIORDANI B, HEIDEBRINK JL, ET AL. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 2001; 58:411-6.
LOPEZ OL, BECKER JT, JAGUST WJ, ET AL. Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry 2006;77:159-65.
DECARLI C. Mild cognitive impairment: preva- lence, prognosis, aetiology, and treatment. Lancet Neurol 2003; 2:15-21.
NORDLUND A, ROLSTAD S, HELLSTROM P, ET AL. The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry 2005; 76:1485.
ELIAS MF, BEISER A, WOLF PA, AU R, WHITE RF, D’AGOSTINO RB. The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol 2000; 57:808-13.
KAUFER DI, WILLIAMS CS, BRAATEN AJ, GILL K, ZIMMERMAN S, SLOANE PD. Cognitive screening for dementia and mild cognitive impair- ment in assisted living: comparison of 3 tests. J Am Med Dir Assoc 2008; 9:586-93.
SCHINKA JA, RAJ A, LOEWENSTEIN DA, SMALL BJ, DUARA2 R, POTTER H. The cognitive change checklist (3CL): cross-validation of a measure of change in everyday cognition. Int J Geriatr Psychia- try 2009 Jul 2. [Epub ahead of print]
LONIE JA, TIERNEY KM, EBMEIER KP. Screening for mild cognitive impairment: a systematic review. Int J Geriatr Psychiatry 2009; 24:902-15.
DECARLI C, MUNGAS D, HARVEY, D, ET AL. Memory impairment, but not cerebrovascular dis- ease, predicts progression of MCI to dementia. Neu- rology 2004; 63:220-27.
COREY-BLOOM J. The ABC of Alzheimer’s disease: cognitive changes and their management in Alzheimer’s disease and related dementias. Int Psycho- geriatr 2002; 14:51-75.
FÖRSTL H, BICKEL H, FRÖLICH L Y COLS. Mild cognitive impairment with predictors of rapid decline. Dtsch Med Wochenschr 2008; 133:431-6.
FÖRSTL H, BICKEL H, FRÖLICH L Y COLS. MCI-plus: mild cognitive impairment with rapid pro- gression. Part I: prevention and therapy. Dtsch Med Wochenschr 2009; 134:39-44.
FÖRSTL H, BICKEL H, FRÖLICH L Y COLS. MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods.
Dtsch Med Wochenschr 2009; 134:88-91.
MANES F, SERRANO C, CALCAGNO ML, CAR- DOZO J, HODGES J. Accelerated forgetting in sub- jects with memory complaints. A new form of Mild Cognitive Impairment? J Neurol 2008; 255:1067-70.
CROOK TH, BARTUS RT, FERRIS SH, ET AL. Age-associated memory impairment: proposed diag- nostic creiteria measures clinical change report of a National Institute of Mental Health Work Group. Developmental Neuropsychology 1986; 2:261-230.
LEVY R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6:63-8.
RITCHIE K, TOUCHON J. Mild cognitive impairment: Conceptual basis and current nosologi- cal status. Lancet 2000; 355:225-8.
SMALL BJ, MOBLY JL, LAUKKA EJ ET AL. Cog- nitive deficits in preclinical Alzheimer’s disease. Acta Neurol Scand Suppl 2003; 179:29-33.
JELIC V, KIVIPELTO M, WINBLAD B. Clinical trials in mild cognitive impairment: lessons for the future. J Neurol Neurosurg Psychiatry 2006; 77:429-38.
LARRIEU S, LETENNEUR L, ORGOGOZO JM, ET AL. Incidence and outcome of mild cogni- tive impairment in a population-based prospective cohort. Neurology 2002; 59:1594-9.
GRAHAM JE, ROCKWOOD K, BEATTIE BL, ET AL. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349:1793-6.
LOPEZ OL, JAGUST WJ, DEKOSKY, ST, ET AL. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cog- nition Study: part 1. Arch Neurol 2003; 60:1385.
NESTOR PJ, SCHELTENS P, HODGES, JR. Advances in the early detection of Alzheimer’s dis- ease. Nat Med 2004; 10 Suppl:S34-41.
DECARLI C, MILLER BL, SWAN GE, ET AL. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001; 58:643-7.
BENNETT DA, WILSON RS, SCHNEIDER JA, ET AL. Natural history of mild cognitive impairment in older persons. Neurology 2002; 59:198-205.
PETERSEN RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256:183-94.
PALMER K, WANG HX, BACKMAN L, ET AL. Differential evolution of cognitive impairment in non- demented older persons: results from the Kungshol- men Project. Am J Psychiatry 2002; 159:436-42.
WAHLUND LO, PIHLSTRAND E, JONHAGEN ME. Mild cognitive impairment: Experience from a memory clinic. Acta Neurol Scand Suppl 2003; 179:21-
PETERSEN RC, THOMAS RG, GRUNDMAN M, ET AL. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352:2379-88.
MITCHELL AJ, SHIRI-FESHKI M. Temporal trend in the long term risk of progression of mild cognitive impairment: a pooled analysis. J Neurol Neu- rosurg Psychiatry. 2008;79:1386-91.
STORANDT M, GRANT EA, MILLER JP, MORRIS JC. Rates of progression in mild cognitive impairment and early Alzheimer’s disease. Neurology 2002; 59:1034-41.
STOKHOLM J, JAKOBSEN O, CZARNA JM, ET AL. Years of severe and isolated amnesia can pre- cede the development of dementia in early-onset Alzheimer’s disease. Neurocase 2005; 11:48-55.
AMIEVA H, LETENNEUR L, DARTIGUES JF, ET AL. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a popu- lation-based study. Dement Geriatr Cogn Disord 2004; 18:87-93.
BUERGER K, TEIPEL SJ, ZINKOWSKI R, ET AL. CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology 2002; 59:627-9.
AMIEVA H, JACQMIN-GADDA H, ORGOGOZO JM, ET AL. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective popu- lation-based study. Brain 2005; 128:1093-1101.
TOUCHON J, RITCHIE K. Prodromal cognitive disorder in Alzheimer’s disease. Int J Geriatr Psychiatry 1999; 14:556-63.
SACUIU S, SJOGREN M, JOHANSSON B, ET AL. Prodromal cognitive signs of dementia in 85-year-olds using four sources of information. Neu- rology 2005; 65:1894-1900.
BARBEAU E, DIDIC M, TRAMONI E, ET AL. Evaluation of visual recognition memory in MCI patients. Neurology 2004; 62:1317-22.
AGGARWAL NT, WILSON RS, BECK TL, ET AL. Mild cognitive impairment in different functional domains and incident Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2005; 76:1479-84.
TIERNEY MC, YAO C, KISS A, MCDOWELL I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 2005; 64:1853-9.
CHEN P, RATCLIFF G, BELLE SH, ET AL. Cog- nitive tests that best discriminate between presymp- tomatic AD and those who remain nondemented. Neurology 2000; 55:1847-53.
LEVY R. Aging-associated cognitive decline Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6:63-8.
FLEISHER AS, SOWELL BB, TAYLOR C, GAMST AC, PETERSEN RC, THAL LJ; Alzheimer’s Disease Cooperative Study. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.Neurology 2007; 68:1588-95.
FARLOW MR, HE Y, TEKIN S, ET AL. Impact of APOE in mild cognitive impairment. Neurology 2004; 63:1898-1901.
PETERSEN RC, SMITH GE, IVNIK RJ, ET AL. Apolipoprotein E status as a predictor of the devel- opment of Alzheimer’s disease in memory-impaired individuals. JAMA 1995; 273:1274-8.
AGGARWAL NT, WILSON RS, BECK TL, ET AL. The apolipoprotein E epsilon4 allele and incident Alzheimer’s disease in persons with mild cognitive impairment. Neurocase 2005; 11:3-7.
TSCHANZ JT, WELSH-BOHMER KA, LYKET- SOS CG, ET AL. Conversion to dementia from mild cognitive disorder. The Cache County Study. Neurol- ogy 2006;67:229–234.
BUERGER K, EWERS M, ANDREASEN N, ET AL. Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study. Neurology 2005; 65:1502-3.
DEVANAND DP, PELTON GH, ZAMORA D, ET AL. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cogni- tive impairment. Arch Neurol 2005; 62:975-80.
MARUYAMA M, MATSUI T, TANJI H, ET AL. Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: Implications for 2 major pathways. Arch Neurol 2004; 61:716-20.
MARUYAMA M, HIGUCHI M, TAKAKI Y, ET AL. Cerebrospinal fluid neprilysin is reduced in pro- dromal Alzheimer’s disease. Ann Neurol 2005; 57:832- 842.
SKOOG I, DAVIDSSON P, AEVARSSON O, ET AL. Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population- based study in 85-year-olds. Dement Geriatr Cogn Disord 2003; 15:169-76.
KILLIANY RJ, GOMEZ-ISLA T, MOSS M, ET AL. Use of structural magnetic resonance imaging to predict who will get Alzheimer’s disease. Ann Neurol 2000; 47:430-9.
FOX NC, CRUM WR, SCAHILL RI, ET AL. Imag- ing of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet 2001; 358:201-5.
KORF ES, WAHLUND LO, VISSER PJ, SCHEL- TENS P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63:94-100.
JACK CR JR, SHIUNG MM, WEIGAND SD, ET AL. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neu- rology 2005; 65:1227-31.
STOUB TR, BULGAKOVA M, LEURGANS S, ET AL. MRI predictors of risk of incident Alzheimer disease: a longitudinal study. Neurology 2005; 64:1520- 24.
BELL-MCGINTY S, LOPEZ OL, MELTZER CC, ET AL. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol 2005; 62:1393-7.
MUNGAS D, HARVEY D, REED BR, ET AL. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology 2005; 65:565-71.
BECKER JT, DAVIS BA, HAYASHI KM, ET AL. Three-dimensional Patterns of Hippocampal Atrophy in Mild Cognitive Impairment. Arch Neurol 2006;63:97-101.
KANTARCI K, PETERSEN RC, BOEVE BF, ET AL. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neu- rology 2005; 64:902-4.
CHETELAT G, DESGRANGES B, DE LA SAY- ETTE V, ET AL. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?. Neurology 2003; 60:1374.
MOSCONI L, PERANI D, SORBI S, ET AL. MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET. Neurology 2004; 63:2332-40.
ANCHISI D, BORRONI B, FRANCESCHI M, ET AL. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 2005; 62:1728-33.
KLUNK WE, ENGLER H, NORDBERG A, ET AL. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Annals of Neurology 2004; 55: 306-19.
WOLK DA, PRICE JC, SAXTON JA, ET AL. Amy- loid imaging in mild cognitive impairment subtypes. Ann Neurol 2009;65:557-68.
CLARKE R, SMITH AD, JOBST KA, ET AL. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55: 1449-55.
SESHADRI S, BEISER A, SELHUB J, ET AL. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002; 346:476-83.
PRINS ND, DEN HEIJER T, HOFMAN A, ET AL. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002;59: 1375-80.
DEN HEIJER T, VERMEER S, CLARKE R, ET AL. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003; 126: 170-5.
MCMAHON JA, GREEN TJ, SKEAFF CM, ET AL. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med 2006;354: 2764- 72.
MORRIS MC, EVANS DA, TANGNEY CC, BIE- NIAS JL, WILSON RS. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 2006; 67:1370–1376.
CHAN DC, KASPER JD, BLACK BS, RABINS PV. Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the Memory and Medical Care Study. Int J Geriatr Psychia- try 2003;18:174–182.
BARNES DE, ALEXOPOULOS GS, LOPEZ OL, WILLIAMSON JD, YAFFE K. Depressive symptoms, vascular disease, and mild cognitive impairment: find- ings from the cardiovascular health study. Arch Gen Psychiatry 2006;63:273–279.
CUMMINGS JL. Behavioral and neuropsychiatric outcomes in Alzheimer’s disease. CNS Spectr. 2005; 10(11 Suppl 18): 22-5.
ABIZANDA P, LÓPEZ-JIMÉNEZ E, LÓPEZ- RAMOS B Y COLS. Síntomas neuropsiquiátricos en deficit cognoscitivo leve y enfermedad de Alzheimer disease. Rev Esp Geriatr Gerontol 2009.100. EDWARDS ER, SPIRA AP, BARNES DE, YAFFE
K. Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia. Int J Geriatr Psychiatry 2009; 24:716-22.
LEE HB, LYKETSOS CG. Depression in Alzheimer’s disease: heterogeneity and related issues. Biol Psychiatry 2003;54:353-362.
MODREGO PJ, FERRANDEZ J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004;61:1290– 1293.
PALMER K, BERGER AK, MONASTERO R, WINBLAD B, BÄCKMAN L, FRATIGLIONI
L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 2007; 68:1596-602.
PETERSEN RC. Conversion. Neurology 2006 14;
(9 Suppl 3):S12-3.
BENNETT DA, SCHNEIDER JA, BIENIAS JL, ET AL. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005; 64:834-41.
PETERSEN RC, DOODY R, KURZ A, ET AL. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58:1985-92.
MARKESBERY W, SCHMITT F, KRYSCIO R ET AL. Neuropathologic Substrate of Mild Cognitive Impairment Arch Neurol. 2006;63: 38-46.
TABERT, MH, ALBERT, SM, BORUKHOVA- MILOV, L, ET AL. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurol- ogy 2002; 58:758-64.
FELDMAN H, SCHELTENS P, SCARPINI E, ET AL. Behavioral symptoms in mild cognitive impairment. Neurology 2004; 62:1199-1201.
LOPEZ OL, BECKER JT, SWEET RA. Non- cognitive symptoms in mild cognitive impairment subjects. Neurocase 2005; 11:65-71.
LYKETSOS CG, LOPEZ O, JONES B, ET AL. Prevalence of neuropsychiatric symptoms in demen- tia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002; 288:1475- 83.
VINKERS DJ, GUSSEKLOO J, STEK ML, ET AL. Temporal relation between depression and cog- nitive impairment in old age: prospective population based study. BMJ 2004; 329:881.
VISSER PJ, SCHELTENS P, VERHEY FR. Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease? J Neurol Neu- rosurg Psychiatry 2005; 76:1348-54.
Deppressive disorders. Diagnostic and statistical manual of mental disorders Washington, DC: Ameri- can Psychiatric Association; 1994.
MANNING C. Beyond memory: neuropsycho- logic features in differential diagnosis of dementia. Clin Geriatr Med 2004; 20:45-58.
SALLOWAY S, FERRIS S, KLUGER A, ET AL. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology 2004; 63:651-7.
MAYOR S. Regulatory authorities review use of galantamine in mild cognitive impairment. BMJ 2005; 330:276.
HERNÁNDEZ L, MONTAÑÉS P, GÁMEZ A, CANO C, NÚÑEZ E. Neuropsicología del envejeci- miento normal. Rev Asoc Colomb Gerontol Geriatr 2007; 21: 992-1004.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.